CVS Health Corp (CVS) : Page Arthur B reduced its stake in CVS Health Corp by 3.18% during the most recent quarter end. The investment management company now holds a total of 52,059 shares of CVS Health Corp which is valued at $5,049,723 after selling 1,710 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.CVS Health Corp makes up approximately 4.91% of Page Arthur B’s portfolio.
Other Hedge Funds, Including , Compton Capital Management Inc Ri reduced its stake in CVS by selling 780 shares or 2.7% in the most recent quarter. The Hedge Fund company now holds 28,128 shares of CVS which is valued at $2,728,416. CVS Health Corp makes up approx 1.46% of Compton Capital Management Inc Ri’s portfolio.Stephens Inc Ar boosted its stake in CVS in the latest quarter, The investment management firm added 1,347 additional shares and now holds a total of 55,662 shares of CVS Health Corp which is valued at $5,419,809. CVS Health Corp makes up approx 0.23% of Stephens Inc Ar’s portfolio.Glenmede Trust Co Na reduced its stake in CVS by selling 35,595 shares or 5.62% in the most recent quarter. The Hedge Fund company now holds 598,159 shares of CVS which is valued at $58,242,742. CVS Health Corp makes up approx 0.34% of Glenmede Trust Co Na’s portfolio.Staley Capital Advisers Inc boosted its stake in CVS in the latest quarter, The investment management firm added 315 additional shares and now holds a total of 363,355 shares of CVS Health Corp which is valued at $35,379,876. CVS Health Corp makes up approx 3.53% of Staley Capital Advisers Inc’s portfolio. Searle sold out all of its stake in CVS during the most recent quarter. The investment firm sold 27,398 shares of CVS which is valued $2,674,867.
CVS Health Corp opened for trading at $97.4 and hit $97.67 on the upside on Monday, eventually ending the session at $97.58, with a gain of 0.15% or 0.15 points. The heightened volatility saw the trading volume jump to 23,97,182 shares. Company has a market cap of $104,041 M.
On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.